Showing results (351-360 of 499) with videos related to

Sort By:
Pageof 50
British Journal of Anaesthesia|February 3, 2000
Comparison of pentastarch and Hartmann's solution for volume preloading in spinal anaesthesia for elective caesarean sectionG W French, J B White, S J Howell, et al.
Electroencephalography and Clinical Neurophysiology|March 1, 1989
Profiles of instant heart rate during partial seizuresP E Smith, S J Howell, L Owen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Circulating insulin-like growth factor II and colorectal adenomasA G Renehan, J E Painter, D O'Halloran, et al.
Thrombosis Research|May 11, 2016
PO-31 - Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancerC C Kirwan, A C Clarke, S J Howell, et al.
Psychopharmacology|January 1, 1980
Ethanol affects the acquisition of informationA Sahgal, S C Ekberg, S J Howell, et al.
Clinical Endocrinology|October 27, 2001
Paradoxical elevations in serum IGF-II and IGF binding protein-2 in acromegaly: insights into the regulation of these peptidesA G Renehan, A A Toogood, W D Ryder, et al.
Clinical Endocrinology|January 1, 1979
Acromegaly due to production of a growth hormone releasing factor by a bronchial carcinoid tumorS M Shalet, C G Beardwell, I A MacFarlane, et al.
Clinical Endocrinology|April 18, 2003
The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarismA M Isidori, G A Kaltsas, L Perry, et al.
Clinical Endocrinology|November 18, 2003
The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacementF M Swords, P V Carroll, J Kisalu, et al.
Clinical Endocrinology|January 13, 2001
Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titrationP J Jenkins, S Akker, S L Chew, et al.
Pageof 50